Sudha Vippagunta is a notable inventor based in Morris Plains, NJ (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative tablet formulations for cancer treatment. With a total of 5 patents to her name, her work has had a meaningful impact on medical science.

Latest Patents

Among her latest patents is a tablet formulation of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide. This invention relates to tablets that comprise this compound, detailing the processes for their production and their uses in treating certain cancers. Another patent focuses on a similar formulation, emphasizing the importance of this compound in cancer therapy.

Career Highlights

Sudha has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in drug formulation.

Collaborations

Throughout her career, Sudha has collaborated with talented individuals such as Elisabete Goncalves and Shau-Fong Yen. These partnerships have fostered innovation and enhanced the development of her patented formulations.

Conclusion

Sudha Vippagunta's contributions to pharmaceutical innovations are noteworthy, particularly in the realm of cancer treatment. Her patents reflect her dedication to improving medical therapies through innovative formulations.

This text is generated by artificial intelligence and may not be accurate.